| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0006 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0009 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.19 | 0.002 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.16 | 0.002 |